Skip to main content

HCV-specific Translation Initiation

  • Conference paper
Viral Hepatitis and Liver Disease

Abstract

In vitro translation experiments involving reticulocyte and HeLa S3 cell lysates have demonstrated that an internal ribosome entry site (IRES) resides within the 5′ untranslated region (UTR) of hepatitis C virus (HCV) RNA. Furthermore, it has been shown that the function of the IRES typical to group II HCV-RNA is more efficient than IRES typical to group I in a cell-free protein synthesis system from HeLa S3 cells. A number of recombinant HCV-RNAs between efficient and inefficient HCV mRNAs were constructed with regard to the 5′UTR, and examined for their mRNA translation efficiences in a cell-free system from HeLa S3 cells. Most recombinant RNAs showed levels of initiation activity similar to or higher than typical group II HCV, strongly suggesting that efficiency of the translation initiation is generally suppressed in nature. These results suggest that persistent infection of HCV in humans requires the downregulated IRES functions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Translation initiation, Internal ribosome entry site, Downregulation

    Google Scholar 

  2. References

    Google Scholar 

  3. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G (1989) Detection of antibody to hepatitic C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321: 1494–1500

    Article  PubMed  CAS  Google Scholar 

  4. Esteban JI, Esteban R, Viladomiu L, Lopez-Talavera J, Gonzalez A, Hernandez J, Roget M, Vargas V, Genesca J, Buti M, Guardia J, Houghton M (1989) Hepatitis C virus antibodies among risk groups in Spain. Lancet ii. 294–296

    Google Scholar 

  5. Hasan F, Jeffers LJ, Medina MD, Reddy KR, Parker T, Schiff ER, Houghton M, Choo Q-L, Kuo G (1990) Hepatitis C-associated hepatocellular carcinoma. Hepatology 12: 589–591

    Article  PubMed  CAS  Google Scholar 

  6. Saito I, Miyamura T, Obayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Kot S, Onj M, Ohta Y, Choo Q-L, Houghton M, Kuo G (1990) Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 6547–6549

    Article  PubMed  CAS  Google Scholar 

  7. Saito M, Hasegawa A, Kashiwakuma T, Kohara M, Sugi M, Miki K, Hattori N, Yamamoto T, Mori H, Ohta Y, Tanaka E, Kiyosawa K, Furuta S, Wakashima M, Tanaka S (1992) Performance of an enzyme-linked immunosorbent assay system for antibodies to hepatitis C virus with two new antigens (c11/c7). Clin Chem 38: 2434–2439

    PubMed  CAS  Google Scholar 

  8. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugiyama T, Shimotohno K (1990) Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 87: 9524–9528

    Article  PubMed  CAS  Google Scholar 

  9. Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Onishi E, Andoh T, Yoshida I, Okayama H (1991) Structure and organization of hepatitis C virus genome isolated from human carriers. J Virol 65: 1105–1113

    PubMed  CAS  Google Scholar 

  10. Enomoto N, Takada A, Nakao T, Date T (1990) There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 170: 1021–1025

    Article  PubMed  CAS  Google Scholar 

  11. Tsukiyama-Kohara K, Kohara M, Yamaguchi K, Maki N, Toyoshima A, Miki T, Tanaka S, Hattori N, Nomoto A (1991) A second group of hepatitis C virus. Virus Genes 5: 243–254

    Article  PubMed  CAS  Google Scholar 

  12. Tsukiyama-Kohara K, Yamaguchi K, Maki N, Ohta Y, Miki K, Mizokami M, Ohba K, Tanaka S, Hattori N, Nomoto A, Kohara M (1993) Antigenicities of group I and II hepatitis C virus polypeptides-molecular basis of diagnosis. Virology 192; 430–437

    Article  PubMed  CAS  Google Scholar 

  13. HanJH, Shyamala V, Richman KH, Brauer MJ, Irvine B, Urdea MS, Tekamp-Olson P, Kuo G, Choo Q-L, Houghton M (1991) Characterization of the terminal regions of hepatitis C viral RNA; identification of conserved sequences in the 5′untranslated region and poly (A) tails at 3′ end. Proc Natl Acad Sci USA 88: 5547 - 5551

    Article  Google Scholar 

  14. Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A (1992) Internal ribosome entry site within hepatitis C virus RNA. J Virol 66: 1476–1483

    PubMed  CAS  Google Scholar 

  15. Laemli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227: 680–685

    Article  Google Scholar 

  16. Pilipenko EV, Gmyl AP, Maslova SV, Svitkin YV, Sinyakov AN, Agol VI (1992) Prokaryotic-like cis elements in the cap-independent internal initiation of translation on Picornavirus RNA. Cell 68: 119–131

    Article  PubMed  CAS  Google Scholar 

  17. Brown EA, Zhang H, Ping L-H, Lemon SM (1992) Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res 20: 5041–5045

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Tokyo

About this paper

Cite this paper

Nomoto, A., Tsukiyama-Kohara, K., Kohara, M. (1994). HCV-specific Translation Initiation. In: Nishioka, K., Suzuki, H., Mishiro, S., Oda, T. (eds) Viral Hepatitis and Liver Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68255-4_32

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68255-4_32

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68257-8

  • Online ISBN: 978-4-431-68255-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics